Qube Research & Technologies LTD Codexis, Inc. Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Codexis, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 59,857 shares of CDXS stock, worth $172,986. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,857Holding current value
$172,986% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding CDXS
# of Institutions
131Shares Held
49.5MCall Options Held
33.4KPut Options Held
21K-
Black Rock Inc. New York, NY6.61MShares$19.1 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.46MShares$12.9 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.26MShares$12.3 Million0.0% of portfolio
-
Baillie Gifford & CO3.45MShares$9.96 Million0.01% of portfolio
-
Opaleye Management Inc. Boston, MA3.12MShares$9.02 Million2.65% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $189M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...